Resveratrol Impacts Alzheimer’s Disease Biomarker The largest nationwide clinical trial to study high-dose resveratrol long-term in people with mild to moderate Alzheimer’s disease found that a biomarker that declines when the disease progresses was stabilized in people who took the purified form of resveratrol. Resveratrol is a naturally occurring compound found in foods such as […]

GREENVILLE, N.C., Aug. 3, 2015 /PRNewswire/ — ArroGen Group, an integrated advanced forensic solutions company, will unveil its new Fingerprint Molecular Identification™ (FMID) technology Aug. 2-8 at the International Association for Identification’s educational conference in Sacramento, Calif. FMID, a new category in forensic science, will enable law enforcement agents, district attorneys and government agencies to build […]

MOUNTAIN VIEW, Calif., July 30, 2015 /PRNewswire/ — Cellecta, Inc., a U.S.-based provider of products and services for gene function analysis and biomarker discovery, announced the release of its pooled CRISPR Guide RNA (sgRNA) Knockout Library targeting all human protein coding genes. CRISPR technology enables researchers to specifically and permanently “knock out” a gene’s function. […]

    New research tracking nearly 1,000 individuals over 38 years found that by measuring 18 biomarkers – everything from liver and lung function to the length of their telomeres – they could measure one’s rate of aging. WSJ’s Sumathi Reddy discusses with Tanya Rivero. Photo: Getty By Sumathi Reddy Sumathi Reddy The Wall Street […]

Johnson & Johnson Innovation Announces 17 Collaborations With Focus on Advancing Global Healthcare Through Transformational Science and Technologies NEW BRUNSWICK, N.J., June 11, 2015 /PRNewswire/ — Johnson & Johnson Innovation today announced 17 new collaborations with research institutions and healthcare companies, bringing the total number of collaborations formed since the 2013 launch of Johnson & Johnson […]

Ordinarily, I differ with Harvard Medical School’s Dr. Jerry Avorn on healthcare issues, particularly when it comes to his views on the pharmaceutical industry. For example, we are on opposite sides of the spectrum when it comes to the importance of the interaction of physicians with drug representatives as well as on the pricing of […]

The U.S. biotechnology arena is undergoing a record-breaking M&A cycle for the industry. After generating M&A activity valued at $235 billion during 2014, the U.S. biotech sector produced more than $100 billion in deals during first-quarter 2015.

While development of personalized medicines has grown since the human genome was first sequenced in 2001, biopharmaceutical sponsors face a number of hurdles that are impeding more rapid market uptake, according to a recently completed study by the Tufts Center for the Study of Drug Development. Fourteen years after the human genome was initially sequenced, […]

Drugmakers including Bristol-Myers Squibb Co and Merck & Co are testing which patients will most benefit from new cancer treatments based on a protein found in their tumors, but that guide, known as a biomarker, may be too unreliable, researchers and health experts said. Bristol’s Opdivo and Merck’s Keytruda are both therapies designed to block […]